Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
i NATIONAL ONCHOCERCIASIS TASK FORCE NIGERIA.
ORIGINAL: English
ANNUAL PROJECT TECHNICAL REPORTSUBMETTED TO
TECHNICAL CONSULTATIVE COMMITTEE (TCC)
AFFICAN PROGRAMME FORONCHOCBRCTASTS CONTROL (APOC)
WHO/APOC, 24 November 2004;-).t ,
,- 3DIoet\rtLCEr'Errlbr'".r.l
[.*l'.-..,.:.,on, Tc, ljri-
AN,
i Ru lIu rf,1,,ItlJ
Dqulu
\
C O UNTRY/I'{ O T E :NIGERI,4 Proiect Name: N,4 SARAWA
Approval vear:1997 Launchins yearz 1998
Reportine Period: From:l't June 2004 To:31.'t May 2005(Month/Year) (Month/Year)
Proi ect yes Lol ttritlepart : (circleone)1 2 3 4 5 (6)7 8 9 10
Date submitted: 23/8/2005 NGDO oartnerz Global 2 000
//.--- -- ,_.-_
ANNUAL PROJECT TECHNICAL REPORTTO
TECHNICAL CONSULTATIVE COMMITTEE (TCC)
ENDORSEMENTPlease confirm you have read this report by signing in the
appropriate space.
OFICERS to sign the rePort:
County
,,b-iNational Coordinator N
Signature:
Zonal Oncho Coordinator Narte
Signature:
Date:.*1
\Date:
tx QQ6u '
/,
c
.*
ar\t;
-)
ely"w:
NGDO Representattve N,ouJo#d 4, Sf'119?u
Signature
Date
This report has been prepared by Namei4
Designati
Signature
.A. (IMAR
Date: .Z44-_ o*- Ot
SPO
Table of Contents
ACRONYMS
DEFINITIONS
FOLLOW UP ON TCC RECOMMENDATIONS..
EXECUTIVE SUMMARY.......
SECTION I:BACKGROIIND INFORMATION......
vVI
I2
3
t.tt.t.t1.1.21.2
GENERAL INFORMATIONDescription of the project (brieJly)...Partnership..POPULATION.., ...
SECTION 2: IMPLEMENTATION OF CDTI2.1 TIMELINE OF ACTIVITIES......2.2 ADVOCACY2.3 MoBILIZATIoNS, SENSITIZATIoN AND HEALTH EDUCATION OF AT RISK COMMUNITIES
) 3-455
2.4
2.52.62.6.12.6.22.6.32.6.42.6.2.72.82.92.9.1
2.9.22.9.3
COMMUNITY INVOLVEMENT...CAPACITY BUILDING..TREATMENT.........Treatment figures... ...
llhat are the cases of absenteeism?......llhat are the reasons for refusal? ...
Briefly describe all known andverified serious adverse events (SAEs) that...........Trend of treatment achievementfrom CDTI project inception to the current year..ORDERING, STORAGE AND DELIVERY OF IVERMECTIN.........COMMUNITY SELF-MONITORING AND STAKEHOLDERS MEETING. .. . . ...
SUPERVISION......Provide aJlow chart of supervision hierarclty...What were the main issues identified during supervision? ...
6677
8
9-10l0l0t0ilI t-12I t-t3l415
16
t6t6t6t6t616
3.1
3.23.33.4
t7t718
l8l9
Was a supervision checHist used? ...
2.9.4. What were the outcomes at each level of CDTI implementation supervision?...2.9.5 Was feedback given to the person or groups supervised?2.9.6 How was thefeedbock used to improve the overall performqnce of the project?
SECTION 3: SUPPORT TO CDTI.......EQUrPMENT............FINACIAL CONTRIBUTIONS OF THE PARTNERS AND COMMUNITIESOTHERFORMS OF COMMUNITY SUPPORTEXPENDITURE PER ACTIVITY..
SECTION 4: SUSTAINABILITY OF CDTI.......
INTERNAL; INDEPENDENT PARTICIPATORY MONITORING; EVALUATIONWas Monitoring/evaluation carried out during the reporting period? (tick any of the
following which are applicable)...What were the recommendations?...How hqve they been implemented?
4.14.1.1
4.r.24.1.3
20
20
202020
WHO/APOC, 24 November 2004iii
4.2 SUSTAINABILITY OF PROJECTS: PLAN AND SET TARGETS (MANDATORY AT 20Yr 3)..
4.2.14.2.24.2.34.2.44.2.54.34.3.14.3.24.3.34.3.44.3.54.3.6
Planning at all relevant levelsFunds... ... ... ..
Transport (replacement and maintenance)... .. . . .
Other resources... ... ...
To what extent has plan been implemented... ... ..
INTEGRATION......Ivermec tin deliv ery mec hanis m...TrainingJoint supervision and monitoring with other programs..Release offunds for project activitiesIs CDTI included in the PHC budget?...Describe other health programmes that are using the CDTI structure and how thiswqs achieved. What have been the achievements? ... ... ...
Describe other issues considered in the integration of CDTIOPERATIONAL RESEARCH... ...
Summarize in not more than one holf of a page the operational research undertaken inthe project area within the reporting period...How were the results applied in the project?... ... ...
2020202020202l212t2t2121
4.3.74.44.4. t
21212t
4.4.22t2t
))
SECTION 5: STRENGTHS, WEAKNESSES, CHALLENGES, AND OPPORTUNITIES.. 22
Section 6: Unique feature of the project/other matter
WHOiAPOC, 24 November 2004lv
Acronyms
APOCATOAtrOCBOCDDCDTICSMLGAMOHNGDONGONOTFPHCREMOSAESHMTCCTOTUNICEFwHoLFEPLFHSHFSMDPMEC/AC
African Programme for Onchocerciasis ControlAnnual Treatment ObjectiveAnnual Training ObjectivesCommunity-Based OrganizationCommunity-Directed DistributorCommunity-Directed Treatment with IvermectinCommunity Self-MonitoringLocal Government AreaMinistry of HealthNon-Governmental Development OrganizationNon-Governmental OrganizationNational Onchocerciasis Task ForcePrimary Health CareRapid Epidemiological mapping of OnchocerciasisSevere Adverse EventStakeholders meetingTechnical Consultative Committee (APOC scientific advisory group)Trainer of TrainersUnited Nations Children's FundWorld Health OrganizationLymphatic Filariasis Elimination ProgrammeFirst Line Health FacilityHealth Facility StaffMectizan Donation Program.
Mectizan Expert Committee I Albendazole Co-ordination.
vWHO/APOC, 24 November 2004
Definitions(D Total population: the total population living in REMO/hyper-endemic
communities within the project area (based on REMO and census taking).
(iD Eligible population: calculated as 84Yo of the total population inmesoAryper-endemic communities in the project area.
(iii) Annual Treatment Objective: (ATO): the estimated number of personsliving in meso/tryper-endemic areas that a CDTI project intends to treatwith Ivermectin a given year.
(iv) Ultimate Treatment Goal (UTG): calculated as the maximum number ofpeople to be treated annually in meso/hyper-endemic areas within theproject area, ultimately to be reached when the project has reached fullgeographic coverage (normally the project should be expected to reach theUTG at the end of the 3'd year of the project).
(v) Therapeutic coverage: number of people treated in a given year over thetotal population (this should be expressed as a percentage).
(vi) Geographical coverage: number of communities treated in a givenyear over the total number of meso/tryper-endemic communities as
identified by REMO in the project area (this should be expressed as apercentage).
(vii) Integration: delivering additional health interventions (i.e. vitamin Asupplements, albendazole for LF, screening for cataract, e.t.c) throughCDTI (using the same systems, training, supervision and personnel) inorder to maximize cost-effectiveness and empower communities to solvemore of their health problems. This does not include activities orinterventions carried out by community distributors outside of CDTI.
(viii) Sustainabilitv: CDTI activities in an area are sustainable when theycontinue to function effectively for the foreseeable future, with hightreatment coverage, integrated into the available healthcare service, withstrong community ownership, using resources mobilized by thecommunity and the government.
(ix) Community self-monitorins (CSM): The process by which thecommunity is empowered to oversee and monitor the performance ofCDTI (or any community-based health intervention programme), with a
view to ensuring that the programme is being executed in the wayintended. It encourages the community to take full responsibility ofIvermectin distribution and make appropriate modifications whennecessary.
Vi
WHO/APOC, 24 November 2004
FOLLOW UP ON TCC RECOMMENDATIONS
The recommendations ofthe last TCC on the project and how they have been addressed.
TCC session_l R
Number ofRecommendation inthe Report 120:
TCC RECOMMENDATION ACTIONS TAKEN BY THE PROJECT FORTCC/APOCMGT ASEONLY
120: i Intensifu advocacy for release offunds by State/LGA
Advocacy has been intensified but State couldnot releasefundsonlylGAtoreleaseN I 96,000($1,468.16) for CDTI activities..
120:ii Used new format in subsequentreport
The new format has been used during currentreport writing.
120:iii Increase the number of CDD The number of CDD has been increased from1808 to 2851.
720:iv Provide missing informationManagement of SEAUTG
Special advocacy workshop.
Revised ATO of 6 LGAs
Monitory/supervision
Ordering,storage and delivery ofivermectin
Plan for integration.
Serious advert events was not recorded.
The project is matured and has attained 100%geographical coverage.
Special advocacy workshop was carried outby Dr. K. Korve in 2001 and the report wassent to APOC Head quarters through NOCPNigeria. We do not have a copy now.
The 6 LGAs from Nasarawa state are beinghandled by LF. Being hyper endemic for LFand hypo-sporadically endemic for Oncho.
Monitory/supervision has been carried out bySPO, SOCTs, LOCTs, HFS and communityleaders.
Ordering storage and delivery of ivermatin iscarried out systematically from community toLGA-state and the NGDO.
Health workers (State/LGA) are beinginducted on CDTI.Integration is being carried out in the projectinvolving Oncho, LF, Schisto, RBM and NPI.
Structures and staff for CDTI are used orinvolved in LF/Schisto/RBM simultaneouslyor whenever scheduled. Similarly none CDTIstaff and facilities are involved in CDTIactivities
I
D(ECUTIVE SUMMARY
The implementation of CDTI in Nasarawa State started, when APOC' letter of agreement wassigned in April 1998. Presently the project is in its 6th year of APOC assistance (June 2004-May200s).
CDTI is being carried out in seven LGAs in Nasarawa State, Akwanga, Kokona, Karu, NasarawaEggon, Lafra, Toto and Wamba. The total population of the 589 at risk villages was 988,161during the period under review.
The state project office carried out village mobilizationAlealth Education in all the 589 villages.
Most villages came out in mass to take Mectizan during distribution June 2004 -May 2005,communities are voluntarily putting efforts to contribute and support their CDDs. A total of 584vi0llages supported 1338 CDDs within the period.
Target, 2851 CDDs: (1043 kindred and 1808 existing)
CDDs trained: 2851 : 100o/o: Kindred 1043 or 100%Old CDDs 1808 or 100%
Target:LOCTs: 2I Trained: 18 : 85.7%Front Line health workers trained is 150 out of I75 or 85.7%
TREATMENT:- Treatment activities were carried out in the 7 APOC assisted LGAs. A total of 753,227
persons out of 988161 were treated representing 76.2oh therapeutic coverage in 589villages representin g I00% geographical coverageThe ration of CDDs to the population is one CDD to 347 people.
Drugs: The project received a total of 3,257 ,842 tablets of mectizan and used 2,315,906 forOncho and 669,549 for LF. Treatment Balance of the drugs in the field is 272,387 .
LGAs contributed N196, 000. ($1,468.16), Lafia LGA N31, 000. (5232.21), Kokona LGAN65, 000. (S486.89), Wamba N20, 000. ($149.81). Nasarawa Eggon N20, 000 ($149.81),ToTo N20, 000, ($149.81), Karu N20, 000, ($149.81), and Akwanga N20, 000, ($149.81).
Communities contributed N562, 445, ($4,213.07) to support CDTI activities in the State
Constraints.' -There was poor counterpart fund from both the state and the LGAs.
Advocacy visit was carried out by the Country Representative Dr. E.S Miri, National DirectorOncho/LF/Schisto in company of Project Administrator and State Oncho Co-coordinator to theCommissioner for Health and Commissioner for Local Government and Chieftaincy Affairs ontheir responsibility for effective control of Onchocerciasis by contributing their quarter ofcounterpart funds in both state and the Local Government.
2
Section 1:
1.1 General information
INTRODUCTION (BACKGROUND INFORMATIOI\N
LOCATION:
Nasarawa State lies between lat.70 and 90 degree North, longitude 7 and 100 degree east. It is bordered onthe North by Kaduna/Plateau State, on the South by Taraba State and on the East by Plateau State and onthe West. The State has an area of 27116.8 sq. km. It lies territory (FCT) Abuja to the South and Benueand Kogi to the West
POPULATION:
Nasarawa State has a total census population of about 2.3 million (based on 1991 census projections). Itis estimated that approximately 900,000 thousand people are at risk of Onchocerciasis and about 446,859thousand are infected with over 1,200 persons visually impaired in the State.
CLIMATE:
Situated in the tropical zone, the climate of Nasarawa State is both hot and cold. The state lies wholly inthe tropics with and pleasant climate and a mean temperature of 600rand 800r (maximum). Annual rainfallvaries from 13l.75cm in some places to l45cm in others. The 3 months in the year, December, Januaryand February are cold and known as the Harmatan season.
PEOPLE:
The state is inhabited by over 24 ethnic groups with common historical and cultural affiliation with nosingle group large enough to either dominate or claim majority position. The people are both hospitableand accommodating and have almost similar cultural and traditional ways of life. People from other partsof Nigeria Co-exist peacefully with the indigenes of the state.
The 24 major tribes found in the state include: - Alago, Agatu, Ake, Arum, , Afor, Eloyi, Bassa, Chessu,Egbura, Egorma, Eggon, Fulani, Gade, Gbagyi, Gwandara, Hausa/Fulani, Kamberi/I(anuri, Kantana,Kwarra, Mada, Mama, Migilli, Rindre, Tiv and Yeskwa. The name of the ethnic groups goes with theirlanguage, 80% of the people live in rural communities with agriculture as their main occupation, 20oh arein urban areas practicing small and large businesses.
CULTURE:
The importance of culture can not be over emphasized considering the rich culture of the state. Theseplay an important role in the lives of the people of Nasarawa state in showcasing its rich culture annuallythrough culture festivals. Amongst them are the famous and annual Oganni cultural and fishing festival atUmaisha of panda Chiefdom in Toto LGA, salt festival in Keana, the Omadege in Nasarawa, Odu inDoma etc.
COMMT]ITIICATION SYSTEM (ROADS) :
Nasarawa State has very good networks running across the state and other neighbouring states of Benue,Plateau and the Federal Capital Territory. Local Government Headquarters are also linked with goodroads to facilitate transportation of human and material resources. The state has and estimated populationof 2.3 people with 70%o of them in rural areas practicing agriculture. Rural settlement are either clustered
J
or scattered with a minimum population of 250 people per settlement30%o of the population live in urbanareas.
HEALTH SYSTEM STRUCTURE:
Nasarawa State Health System is well structured such that Oncho Control unit is under thedirectory of PHC/DC, which is headed by the SPO who is answerable to the Director PHC/DC ofthe Ministry of Health. All communication are passed through the Director PHC/DC up to theHon. Commissioner.At the LGA level, each has five Primary Health Care district referred to as referrer centres headedby District Head Supervisor. In each health district there are health posts or first line healthfacilities (FLHF) headed by health facilities staff (HFS) who over see the activities of CDDswithin their catchments areas.(See table 2 on population of CDTI LGAs)
A Primary Health Care Director who supervises all Health activities in the LGA is the head ofeach LGA health department. The State Ministry Health developed policies and sends them theLGA for implementation. Each LGA has 33 staff that are involved in CDTI activities. At thestate level, there are 7 personnel who carry out Onchocerciasis Control activities. They include:The SPO, 4 SOCTs , I Data Clerk, and I Driver. The programme is integrated in to the PHCsystem at both the state and local government levels.
Table 1: Number of health staff involved in CDTI
District/LGA Number of health staff involved in CDTI activities
Total Number ofpercentagehealth Staff n theentire project area
B1
Br:BzlB/*100
Number of health
staff involved inCDTI
B2
AKWANGA 301 33 t0.9%
KARU 329 33 t0%
KOKONA 218 33 15.t%
LAFIA 342 33 t4%
NAS/EGGON 256 33 12.8%
TOTO 216 33 15.2%
WAMBA 207 33 15.9%
Total 1,869 231 12.3o/o
4
1.1.2 Partnership (role of each partner) state, LGA/Communities
The state is the implementing agency and her major roles included planning, staffing, manpowerdevelopment, advocacy, counterpart funding, Mobilization/Health education and supervision/distribution.NGDOs are found mostly in cities and state headquarters. They provide cash and logistics to CDTIimplementation, provides technical assistance to the project, advocacy to high government functionaries,procurement of Ivermectin tablets from MSD and development of Health education materials, while MSdprovides mectizan tables, though WHO, Nigeria.
The roles of Local Governments include Planning, Staffing, Training, Distribution, Supervision,Mobilization and Health Education.
The roles of the communities include collection of mectizan, selection of CDDs, provision of registrationbooks and incentive to CDDs.
CBOsz These are philanthropic and religions organizations based in urban communities. They providesupport to CDTI implementation such as providing transportation to CDDs during training, mobilizationand supervision.
Policy makers: Budget and release of funds for CDTI implementation and give technical advice forsmooth running of CDTI activities.
I.2 POPULATION:Table 2: Communities and population at risk in the entire project area whether they are treated or notduring the reporting period.
Number of Communities/Villages in Population of
CDTIDistrict/LGAsin the entireproject area
Totalpopulation in theentireproject
area
Meso-endemic zonein the project
area
Ar
Hyper-endemic zonein the project
area
A2
Total inmeso/hyper-
endemiczone
Ar=A/+Ar
Meso-endemic zonein the
projectareaAI
Hyper-endemic
zone in theproject
areaA5
Total inmeso-hyper-
endemiczone
Ac=A/+As
Ultimatetreatment
Goal
(UTG)AKWANGA r45676 102 102 145676 145676 I I 8943
KARU 168622 99 99 168622 168622 152941
KOKONA 71629 47 47 71629 71629 64347
LAFIA 262079 72 72 262079 262079 228608
N/EGGON 144587 82 85 144587 144587 134186
TOTO 88007 99 99 88007 88007 83291
WAMBA 107s61 85 85 107561 107561 95400
Total 988161 388 201 589 754478 233683 988161 877716
5
I
WG: calculated as the maximum number to be treated annually in meso/hyper endemic areas within theproject area, Ultimately to be reached when the project has reachedfull geographic coverage (normallythe project should be expected to reach the UTG at the end of 3'd year ofthe project).
The seven CDTI endemic LGAs have a population of 988161 and732067 eligible population.Source ofdata on the table above arel. CDDs2. HFS3. DHS4. LOCts
SECTION 2: Implementation of CDTI
2.1 Timeline of activities
The project year for CDTI implementation is from June 2004 to may 2005 (One year). Majority of CDTI
activities especially training, distribution, supervision and collection of mectizan etc. are done during the
dry season period when people have less to do in their farms. High peak period of activities falls between
January and July (See table 3,). However, this call spills over to December.
Table 3: Timeline of activities June 2004 - May 2005
llB: All activities are targeted with occasional spot-checking and co-ordination of supply.
6
DiSULGA
Mobilization ofCommunities
Treining July 2004to May 05
Census/Update August2004-March 2005
Drug distributionAugust 2004 - May
2005
Supcrvision Aug.2004
- May 2005
Startingmonth
Completionmonth
Startingmonth
Completionmonth
Startingmonth
Completionmonth
Startingmonth
Completionmonth
Startingmonth
Completionmonth
Akwanga June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Karu June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Kokona June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Lafta June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Nas/Eggon June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Toto June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
Wamba June 04 May 05 July 04 May 05 Aug.04 March 05 Aug.04 May 05 Aug.04 May 05
2.2 Advocacy
Advocacy visit was carried out to Commissioner for Health, Permanent Secretary Minishy for LocalGovernment and Chieftaincy Affairs and the LGA Chairmen and Community leaders of the sevenendemic LGAs on sustainability of the CDTI activities: by NGDOs Country Representative, PA./OnchoCoordinator and Director LF, Schisto and Oncho.
The main issues discussed were on sustaining the programme through counterpart contribution. Promiseswere made by State and local Government for the contribution of their counterpart fund. However, LGAsgave N196,000 ($1,468.16) for the collection of the additional APOC donated equipments; and to supportCDTI activities.
The projectwishes to requestthe assistance of NOCP and Global 2000 The Carter Centerto assist inthearea of advocacy to the executives at both state and local government levels to facilitate the release offunds for project activities.
2.3 Mobilization, Sensitization and health education of at risk communities.The objective ofthe project was to reach and mobilize 589 communities concerning CDTIactivities through: -
The use of Town announcer or town criers, posters, videos, radio jungles etc
Health education of Women and Minority groups is done through Women Leaders, Religionsleaders, Market Women Union, Youth Leaders etc.
- The response of target communities/villages: they accepted the CDTI and promised to giveincentive to CDDs in kind or in cash, as the programme belong to them.
The outcome of the mobilization/health education was impressive at the community levels, all589were mobilized of their roles and responsibilities in CDTI. This is indicated by a therapeutic coverageof not less than 76.2% and 100%o geographical coverage.
7
District/LGA Number of communities/villages w withcommunity members rs supervisors
Number of CDDs and thecommunities involved
Number ofcommunities/villeges with
femalc CDDsTotal
no,Communitiesin theentireproject
area
B4
Number withcommunitymembers as
superyisors
Bs
Percentage
Be:Bs,/B.* 100
MaleCDDs
B7
FemCDDs
Bs
Total
Bs=Bu*Br
Number ofcommunitie
s withfemaleCDDs
Bto
Percentage
Brr=Bro/B{*100
AKWANGA 102 t02 t00% 321 65 386 t6 16.8%
KARU 99 99 100% 326 134 460 34 29.r%
KOKONA 47 47 100% 196 69 265 17 26.0%
LAFIA 72 72 100% 447 144 591 36 24.3%
NAS/EGGON 85 85 100% 442 123 565 3l 21.7%
TOTO 99 99 100% 216 66 282 l8 23.4%
WAMBA 85 85 100% 289 r3 302 5 4.3%
Total s89 589 100% 2237 605 2851 157 21.2o/o
2.4 Community involvement
Table 4: Communities participation in the CDTI
Comment on:
I
Comments on females performance on CDTI activities:-
The attendance of female members of the Community at health education is notencouraging, as men are not giving that opportunity to women. In all endemic communitiesfemale CDDs are selected based on socio cultural and region believes.
In all the endemic communities female CDDs are selected based on socio cultural andreligious beliefs.
2
8
l\)ur
oA)
!s(,)
(<
UO
OQ
(D
a(D
}l
tD.)
+-l-l-.lrile'rrB'?V2=a-55E55IqEqEI,qqqe,oIEUrv:U#*8ts@ Ef * E-.1 tslsd.ilh','
[&[HH
lilE
lolur
-,
='mD
6o-i
6oi
tr
D
oilEgs" *
\ooi;b 6'q.
o\o\ o o\ o o o o o*ci
b.lt, o\ l.J A UJ N) 5 lvz{NJ
ou
5{t,o6 5 A o\ -{ - o\ &F
I6cs
6\6\ o o\ ro
E
r,
5Xa
s o\UI
1..) N) NJ l.J NJ l9 o
aoI,,O
h.)Ul \o N) o\
z{6'
o€\
5o t\)t\) A t\)
t\) o\ N)5 t)
UJ \o s-eo<5s
o\UI
t\) N N) NJ tJ IJ oi+i
6Elo
3*=3*iE,S TIPi
zEl
oo
o!,
o=6Io
oA)
=G
5Ur \t UJ { { \) { -J
\d
(i J\od
-t |.) O N) o ;zstt)s N { { o\ o\
\o6(Ds
.AUI { \t { { -_t { i\
-J
F
6
oo
d
FJoFl
l,
oo@
Vrd3E6
a
l!G
0q
\oPos
t.lt,(r\\o
t,t\) o o\ \o N)o\ .l:
o\ @ {oBo
\o.rUI UJ
o t')o\oo
t\)N)
ooo ooN)
o
6\hJ5
qo\D
N\o{UJ6\o oo
N6 N)
oo5
z
avl
\ooo\o6\
t\)(,ro\\o
UJoNJ
o o\ \o t)o\ Ao\C)
OJCA
(oN)
5-i
UI
F
Ho),
z
oo
oo
J
Trainees
Type of trainingCDDs
Othercommunitymembers e.gcommunitysupervisors
HealthWorkers(Frontlinehealthfacilities)
MOH staff orOther
Politicalleaders
Others (specify)
ProgrammmanagementHow to conductHealth educationManagement ofSAEsCSM I ISHM IData collection IData analysis I IReport writing I IOthers (specify)
Table 6: Type of Training undertaken
Training caruied out during the reporting period)
2.6 Treatments
2.6.1 Treatmentfigures:
Total census populationEligible populationTreated populationTherapeutic coverageGeographic coverage
988,1618777t7753,22776.2%100%
2.6.2 Causes of absenteeism:Absenteeism reported during the distribution period were 6608 persons or 0.75yo of the total eligiblepopulation.
REASONS:(1) Not treated at the time community needed/selected(2) Out for farming during raining season(3) Out for other businesses during treatment
l0
-_]
(l)(2)(3)
2.6.3 Reasons for refusal:
Reaction during treatmentNot willing to give incentive to the CDDsFeel they don't have any infection to take the drug
ln case the project did not have any cases of serious adverse events (SAE) during this reportingperiod, please tick in the box
2.6.4
No SEA case to reportI
Table 7: Treatment and SAEs by district/LGA in all areas at risk (June 2004-may 2005)
District/LGA Communitics/Villages Population NO. ofper.ref.
treat
Numberoof
rbscntism
NO.of
SAEs
NO. ofseriousadverscevents(SAEs)
rcf.
post/hosp
Total #ofcom.lvill. in
themeso/hyp
er-cndemic
orcls
D,
AnnualTreated
Objective
D:
No, ofcomm-unitics/villagc
s
trcated
D3
Geogcoveragc
(%)
IFDs/Dr*100
Totrl pop.of the
meso/hyper-endcmic
erers
D.
Anu.Trc-ated
Objective
Dr
No.r ofpcrstrc
etcd
D7
Thera-peuticcov.(%)
AKWANGA 102 93898 102 100 145676 I I 8943 I I 8943 8l 6% 0 0 0 0
KARU 99 144949 99 100 168622 15294t I 52000 9O.1o/o N/A 376 0 0
KOKONA 47 157313 47 100 7 t629 64347 s8200 8t 2% 2459 0 0
LAFIA 72 149249 '7) 100 262079 228608 150997 57 60/o 0 0 0
NAS/EC,C,ON 85 I 361 46 85 100 144s87 134186 129500 89.5o/o 1874 0
TOTO 99 80349 99 100 88007 83291 78542 592% I 899 0 0
WAMBA 85 70644 85 100 I 0756 I 95400 6s045 60 5% 0 0 0
Total 5E9 732067 s89 100 9E8l6l E77716 753227 76.2Vo N/A 0
ll
S/N Age Sex Villegcof
ongrn
Datcmectizrn
was teken
Drtc l"sympts
appeared
Sympt Healthstrtusbcforeteking
mcctizan
Drtcofedm in
healthfaci.
Date ofdismissal fromhealthfacilitv
Results oftests (thick
blood smear
Outcomc of
prognosis
Extenuating orcomplicatingcircumstances
No serious adverse events were experience/reported
Table 8: Cases of serious adverse events (SAEs) that occurred during the reporting period
2.6 Trend of treatment achievement from CDTI project inception to the current yearSince treatment started in 1998 - May 2005 there has been a progressive increase in the number ofpersons treated each year.
t2
Year Communities/villages PopulationTotal # ofcom/villagesin themcso/hypcr-cndemicareas
Er
AnnualTrcatedObjcctives
Ez
Numbcrofcommunities/villagcs treated
Er
Geogcov.(o/o)
ErE!Er *100
ATOcov.(%)
Es=EJE2*100
Totalpop.ofthemeso/hyper-endemic areasE6
AnnuelTrcatcdObjectives
E7
Numbcrofpen.treatcd
Er
Thcrapeuticcovcrage(o/o)
Eg=EE/E
6
100
ATOcoverlge (o/o)
Ero-Er/E:*100
UTGcovcrlgc(o/o)
t998t99 589 42E000 589 100 100 1,3217
64
685,000 657211 49.7
%
96% 765
199912000 s89 43s930 589 100 100 1,289,8
3
l0l 3 160 8335 l 0 64.6
%
82.2% 79 6%
2000/2001 589 538400 589 100 100 894013 756258 717881 80.2
%
94.9o/o 94.9%
2001n002 589 538400 589 100 100 113447
7
1 03398 I 943897 83.2
o/o
9t.2% 91.2o/o
2002t2003 589 785085 589 100 100 974608 911278 1046578 106
7
fi42 106.7
2003D00,4 589 732067 589 98 9o/o 98.9% 872768 860768 7 12702 8l.6
%
82 Jo/o 82.8%
200412005 589 '132067 589 t00% 100% 988161 877716 7s3227 762
%
85.8% 85 8%
Table 9: Treatments and coverage for June 04 - May 05 by calendar year for entire project area.
UTG for the project area: 877,716 persons
l3
2,7 Ordering, Storage and delivery otlvermectin
MOHMectizanI ordered/applied for by -
wHo tr T'NICEF tr NGDO
UI\ICEF tr NGDO
Other (Please speciry): MOH
Mslfflivered bv - (Ptease tick the appropriate answer)r
Other (Please specifu)
Before the procurement of mectizan is done by NGDo, each CDD calculates his or her mectizanrequirement based on the eligible population registered and multiply by average of three tablets.Together with FLHFS they arrived at their requirement for each village who send to the focalpersons at the LGA (LOCT) to the DHS then to the SOCTs. The SOCTs/SPO compile allrequirements for the seven LGAs and send to the NGDO for procurement. When mectizan arrivesin the country, WHO clears from the Customs and stores it in their ware house. The NGDOs thencollects the drugs to her store. The state project officer put up requisition for each LGA.
When mectizan is supplied to the SPO by NGDO, SOCTs collect for their respective LGAs anddeliver to the LOCT team leaders at the LGA levels. The team leader then hand over the drugs to
The five DHS for allocation to the five FLHF or collection centers where CDDs come to collectfor their respective communities.
Table 10: Mectizan Status
State/Dist/LGA
Number of Mectizan tablets
Requested Received Used Lost Wasted Expired balance
Oncho LF
AKWANGA 451,344 451,344 281980 166020 3344
KARU 773,008 773,008 613882 103625 s5501
KOKONA 328,034 328,034 I 84389 2300 141345
LAFIA 675,758 675,758 253258 397604 25096
N/EGGON 597705 597705 597705
TOTO 249,442 249,442 203157 46285
WAMBA 182,351 182,351 181535 816-
STORE
Total 3257842 3257842 2315906 669549 272387
t4
2.8 Community self-monitoring and stakeholders meeting not carried out during period
Table 11: Community self-monitoring and stakeholders meeting not carried out
District/LGA Total # ofcommunities/villagesin the entire project
area
No of communitiesthat carried out selfmonitoring (CSIvf)
No of communitiesthat conducted
stakeholders meeting(sHIvr)
AKWANGA 102 0 0
KARU 99 0 0
LAFIA 72 0 0
KOKONA 47 0 0
N/EGGON 85 0 0
TOTO 99 0 0
WAMBA 85 0 0
TOTAL 589 0 0
l5
2.9 Supervision
Flow chart of supervision hierarchy2.9.1
ZONAL COORDINATOR
NGDO (Dir./PA) STATE
sPo/socT
LGA
LOCT/DHS
CLINIC
HFS
COMMUNITY COMM.LEADERS/CDDs
L------------
2.9.22 What were the main issues identified during supervision?
Some CDDs do not use durable registers like hard cover note booksSome communities give incentive to their CDDs while others don'tInadequate logistic for supervision at LGA levelslnadequate IEC materials.
2.9.32 Was a supervision checklist used?a. Supervision checklist is used during supervision by each level of health staffinvolved in CDTI activities.
2.9.4: What were the outcomes at each level of CDTI supervision?- SOCts are involved in mobilization, training, and supervision at the LGA level
while LOCts and DHS mobilize, train, monitor and supervise health facility staffand CDDs at community level.
I2
3
4
16
SECTION 3: SUPPORT TO CDTI
3.1. Equipment
Table 12: Status of equipment
Condition of the equipment (F - functional, CNFR - Currently non functional but repairable, WO Writtenoff) NA NOT AVAILABLE.
s/N TYPEOF
EQUIPMENT
APOC MOH DISTRICT/LGA NGDO/GLOBAL2000
OTHERS
No Condition No Condition No Condition No Condition No Condition
I Vehicle I 1t|/O Nil Nil Nil Nil2 Motor-
cycle14 4WO
10FNil Nil 12 WO S IrO Nil
J Comp. 2 IFII4/O Nil Nil Nil Nil4 Printer 2 IFIWO Nil Nil Nil Nil5 Photo-
copierI I CNFR Nil Nil Nil Nil
6 Tele-vision
I IF Nil Nil Nil Nil
7 Video I 1F Nil Nil Nil Nil8 Generat
orI IF Nil Nil Nil Nil
9 Stabilizer
I 1 CNFR Nil Nil I CNFRI Nil
10 Phone Nil Nil Nil Nil I F Nilt1 Standin
c-fan
Nil Nil Nil Nil I F Nil
t2 Refri-Rerator
Nil Nil I F Nil Nil Nil
t3 Tables Nil Nil 6 F Nil NA 7 F Nil14 Chairs Nil Nil 6 F Nil NA 3 F Nil15 cup-
boardNil Nil Nil Nil Nil Nil
16 File -cabinet
Nil Nil Nil Nil 2 F Nil
t7 P,Asystem
Nil Nil Nil Nil Nil Nil
t8 Bicycles 35 2tF9 CNFR5WO
Nil Nil t6 13F3WO
NIL
19 Officesafe
Nil Nil Nil Nil Nil Nil
t7
Contributor Year I (2003) Year 2 Q004) Year 3 (2005)Totalbudgeted
Grs$)
Totalreleased(us$)
Totalbudgeted(us$)
Totalreleasedrus$)
Totalbudgeted(US$)
Totalreleased(us$)
The Ministry of
Health (MOH)
I 498.1 Nil 1498.1 Nil I 498. I 1498.1
DistricVLGA 112.3 112.3 973.7 973.7 1468.16 I 468.16
The Local NGDO (S) Nil Nil Nil Nil Nil Nil
The NGDO partner(s) r27828.58 97750.233 95099.333 9298r.653 231s07.11 231507.11
Others Nil Nil Nil Nit Nil Nil
Communities 1303.3 1303.3 1746.6 1746.6 422 6522.6
APOC Trust Fund 49622.57 49622.57 29542.91 29542.91 31500 3r500
Total 180364.85 148788.403 128860.643 125244.863 266395.37 272495.97
3.2 Financial contribution by all partners for the last three years
Table 13: (N133.50 : us$1.0
If there are problems with the release of counterpart funds. How were they addressed?Advocacy visits were made to the relevant policy makers.Additional Comments;High-level advocacy to the various government levels by NGDO, APOC, and NOCP is solicited
3.3 OTHER FORMS OF COMMUNITY SUPPORT:In Nasarawa State most of the incentive for CDDs are in cash and the food items such as yams,rice, g/corn etc.
Indicate in table 14 the amount expended during the reporting period for each activity listed.
Write the amount expended in US$ using the current united nation exchange rate to local currencyIndicate exchange used here N133.5 = US$1.000
l8
S/N ACTIVITIESNGDO APOC SMOH LGA
Akwanga Karu Kohona LaJiya N/eggon Toto Wamba
I Drugs delivery NA Nil Nil
2 Mobilizahon 34,125.00 Nil Nil
3 Training of CDDs 47,600.00 Nil Nil 486.80
4 Training of FIFs all
level
32,041.66 Nil Nrl
5 Supervising 168,223.33 Nil Nil 232.20
6 Intemal monitoring
of CDTI activities Nil Nil Nil
7 Advocacy visits to
health and politrcal
authonties
7291.66 Nil Nil
8 IEC materials Nil Nil Nil
9 Summary (reporting)
forms for treatment Nil NilNrl
t0 Vehicles/lvlotorcycles
/Bicycles
maintenance 90,650 00 28,000 Nil r49.90 149.90 149.90 149.90 149.90
1l Office equipment
(e.g computers,
printers etc) 2,333.33 3,500 Nil
t2 Side reaction
drugs/stationerres
39,974.66 Nrl Nrl
Total $2551.6 31,500 Nrl 149.90 149.90 486.80 232.20 149.90 149.90 149.90
3.4 EXPENDITURE PER ACTIWTY
Table 14: Project expenditure June2004 - May 2005N135.5 (us$1.0)
. Most activities were sustained by NGDO funding and the good will from the communitieso Expenditure per activities by Communities was not given.
t9
SECTION 4: Sustainability of CDTI
4.1. Internal; independent participatory monitoring; Evaluation
4.1.1 Was Monitoring/evaluation was carried out during the reporting period. NOYear I Participatory Independent monitoring
Mid Term Sustainabi lity Evaluation
5 year Sustainability Evaluation
_Internal Monitoring by NOTF
4.1.2. What were the recommendations?
4.1.3. How have they been implemented?
4.2. Sustainability of projects: plan and set targets (mandatory at Yr 3)
Wastheprojectevaluatedduringthereportingperiod?-zo-
Was a sustainability plan written?
When was the sustainability plan submitted? April 2003
4.2.1. Planning at all relevant levels
Arrangement put on ground to sustain and implement CDTI activities in the state and LGAs
a. Planning, will be carried out at both state and LGA
b. The funds for running of CDTI implementation will be sourced from state government,
local government, communities and philanthropic organizations (CBOs)
4.2.2. Transport (replacement and maintenance)
Maintenance of project vehicle is carried out by GRBP and APOC. State Ministry of Health and
the LGA are yet to address this issue, but hopefully when their financial standing improves they
will embark on it soon.
4.2.3. Other resources - will be sourced from philanthropic organizations and CBOs.
4.2.4. To what extent has the plan been implemented:-
The recommendation of sustainability evaluation from GRBP stated thus-
a. Non release of counterpart funds
b. Non usage of measuring sticks by few CDDs
c. No incentive for CDDs in some communities
20
4.3.1
4.3.2
4.3.3
4.3.4
4.3
4.3.5
4.3.6
4.3.7
d. Few CDDs do not know how to calculate their drug requirement during the evaluation.
i. Counterpart funds issue has been addressed through the release of 5.4 million naira by
Nasarawa State.
ii. CDDs now use measuring sticks during treatment.
iii. Communities now give incentive to their CDDs to an extent.
iv. Retraining of CDDs by health facility staff has addressed the issue of drug requirement by
CDDs.
Integration
Integration of CDTI into PHC structure and the plans for complete integration:
Ivermectin delivery mechanisms - Donor, Federal, National, State, LGA, Community
Training - Training for CDTI activities are integrated with LF/Schisto and RBM training
simultaneously.
Joint supervision and monitoring with other programs- LF, Malaria, Schisto
Release of funds for project activities - release of fund by Ministry of Health is not forth coming.
Money was budgeted in 2002 but not released. However, 5.4 million has been budgeted and
released in 2005.
Is CDTI included in the PHC budget?
CDTI is included in the Ministry of Health budget for the year 2005.
Health programmes that are using the CDTI structure. LF, NPI and RBM Programmes.
Issues considered in the integration of CDTI- this is in the pipe line in the Ministry of Health and
Ministry for Local Government and Chieftaincy Affairs.
Operational researchTo summarize in not more than one half of a page the operational research under taking areawithin the reporting period? Yet to commence operational research.
4.44.4
4.4.2 How were the results applied in the project? The result will be used during distribution andtreatment period if carried out.
I
2l
SECTION 5: Strength, Weakness, Challenges and opportunities
Strength;
* High coverage geographical/therapeutic.* Time of treatment has been reduced because of more hands in the job.* More awareness by community on self-ownership.* Training of Oncho Team on CDTI activities is now a targeted training.* Collection centers are now nearer to the community making things easier for the CDDs
Weakness:
.t Drugs passing through many hands before reaching the community causes delay on treatment.* No adequate incentive to the CDDs by the communities.* No adequate counterpart funds by the State and Local Government.* Some CDDs left their job without handing over the registration books to their village heads* Clashes in some of the LGAs e.g. Toto LGA.* Strike in some LGAs.
Challenges:
1. Poor counterpart fund from state and local government
2. Poor incentive to CDDs by some communities
Recom m endations/Opportu nities :
* Overallbudget for State and LocalGovernment should include CDTI activities* Community should intensifu giving incentive to the CDDs.':' All hands should be on deck for all tiers of govemment and community for the sustarnabrlity of the CDTI actruties.
Section 6: Unique feature of the project/other matters
The project operations were integrated where the same staff at the State, Local and Community level wereinvolved in CDTI, LF elimination programme, Schistosomiasis control and roll back malaria activities
The project had the following achievements during the period under this reporting period in addition toCDTI:
NASARAWA ADD _ ON ACTIVITIES TO CDTI IN NASARAWA.
o *The ATO was based on gestimation of urban populations thus under estimated.o Entomological studies of Black flies and Mosquitoes were also ongoing to monitor impact on Lymphatic
Filaririasis and Onchocerciasis,
SAi PROGRAMME VILLAGES POPULATION
ATO COVERED ATO Vo ATO PERSONSTREATED
ATOVo
I Lymphatic Filaria 4 4 100% 786,641* 249,615 133.7%
2 Schistosomiasis 101 97 96Yo 56,910 55,107 96.\Yo
J RBM-ITNs
Distribution 103 99 96.1 28,983 24,872 85.8%
22